AFRM vs EDIT
Affirm Holdings Inc (AFRM) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Affirm Holdings Inc (AFRM) is a software - infrastructure company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported AFRM revenue for 2025-06-30 was $3.22B. Net income was $52.2M. Revenue was up 38.8% from 2024-06-30 to 2025-06-30. AFRM currently screens at market cap $28.80B and trailing P/E 589.7.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
AFRM currently screens at market cap $28.80B and trailing P/E 589.7. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the AFRM and EDIT stock pages for the full models.
Not investment advice.